Huntalase Intraventricular Injection 15mg, containing Idursulfase beta (genetically recombined), is manufactured by Clingen. This injectable drug, with YJ code 3959423A1022 and standard 15mg 1mL x 1 bottle, is an enzyme replacement therapy for mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome.
Huntalase Intraventricular Injection 15mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
